Health Condition 1: E135- Other specified diabetes mellituswith circulatory complications
Conditions
Interventions
Intervention1: NA: NA
Control Intervention1: NA: NA
Sponsors
Novo Nordisk India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: The following criteria are necessary for subjects to be eligible for this study: 1.Male of female individuals with T2DM, greater than or equal to 18 years of age 2. A confirmed diagnosis of T2DM, and the availability of data before ethical clearance at every participating institution 3. Medical records available between 01 January 2024 to 30 September 2024 ought to have the data points required for the primary and secondary objectives. Medical records must have at least 6 months (greater than or equal to 180 days) of follow-up data from the date of diagnosis
Exclusion criteria
Exclusion criteria: Subjects who meet any of the following criteria will be disqualified from entering the study: 1.Diagnosis of Type 1 diabetes, or maturity-onset diabetes of the young (MODY) 2.Known congenital heart disease or malformation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of individuals with established CVD i.e. who have been diagnosed with either cerebrovascular disease, coronary heart disease (CHD), heart failure, cardiac arrhythmia or conduction abnormalities, aortic disease, peripheral artery disease (PAD), or carotid artery diseaseTimepoint: At least 180 days (6 months) from the date of diagnosis | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of individuals with renal disease & cardio-renal risk factors. Characterize individuals based on demographics, clinical parameters & treatment patterns Timepoint: At least 180 days (6 months) from the date of diagnosis | — |
Countries
India
Contacts
Public ContactDr Maya Sharma
Novo Nordisk India Private Limited,
Outcome results
None listed